Work

Risk Factors and Outcomes Analyses at 36 Months of a Prospective, Randomized, Multicenter, Trial of Daclizumab Induction in Simultaneous Kidney–Pancreas Transplant Recipients

FWCI: 0.191
Cites: 13
Cited by: 4
Related to: 10